Fecal Transplant

C. diff vaccine moves closer to reality with launch of large Phase III trial

C. diff vaccine moves closer to reality with launch of large Phase III trial

By

A potential Clostridium difficile vaccine performed well in initial tests and now has moved into a large Phase III trial, researchers announced today. The news from developer Sanofi Pasteur raises hopes that the antibiotic-resistant infection can be prevented in long-term care facilities and other settings where it has become a deadly scourge.

FDA responds to provider pressure, backs off stricter control of fecal transplants for C. diff

By

Individuals with treatment-resistant Clostridium difficile can undergo fecal transplants after giving informed consent, the Food and Drug Administration recently announced. This is a victory for providers, who pushed back after the FDA recently announced it would tighten regulations around the transplants.

FDA — full of poop?

FDA — full of poop?

By

Every few days I read the Food and Drug Administration (FDA) news to see if there is anything relevant to eldercare that I should be aware of. Recently, I came across an extremely eye-opening item.

Fecal transplants to treat C. diff now need FDA approval

By

The Food and Drug Administration is moving to tighten regulations around fecal transplants, which research has shown to be an effective treatment for Clostridium difficile infection.